Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy

Exclusion Criteria

• •Patients presenting a contraindication to the use of Adalimumab:
• •hypersensibility in Adalimumab or in one of the excipients.
• •Patients presenting an evolutionary tuberculosis or the other severe infections such as sepsis and opportunist infections
• •presenting patients one cardiac insufficiencies moderated in severe
• •Patients under anakinra or abatacept
• •current participation in another study of clinical research